Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines Conference

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company, announced that CEO Paul Bolno will participate in an analyst-led fireside chat at Chardan’s 6th Annual Genetic Medicines Conference on October 4, 2022, at 3:15 p.m. ET in New York City. A live webcast of the event will be accessible on the company's Investor Relations page, with a replay available for a limited time afterward. Wave Life Sciences focuses on developing innovative treatments for genetically defined diseases through its proprietary PRISM platform.

CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Chardan’s 6th Annual Genetic Medicines Conference in New York City on Tuesday, October 4, 2022, at 3:15 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com 

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

When is Wave Life Sciences' CEO participating in the Chardan conference?

Paul Bolno, CEO of Wave Life Sciences, is scheduled to participate in the Chardan’s 6th Annual Genetic Medicines Conference on October 4, 2022, at 3:15 p.m. ET.

Where can I watch the Wave Life Sciences conference presentation?

The presentation can be watched live on the Investor Relations page of Wave Life Sciences' corporate website.

What is Wave Life Sciences' focus in the genetic medicines field?

Wave Life Sciences is dedicated to developing life-changing treatments for genetically defined diseases using its proprietary PRISM drug development platform.

What stock symbol represents Wave Life Sciences?

Wave Life Sciences is represented by the stock symbol WVE on Nasdaq.

Is there a replay available for the Wave Life Sciences conference?

Yes, a replay of the presentation will be archived and available on the Wave Life Sciences website for a limited time after the event.